ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis
Open Access
Abstract
Atherosclerosis is a chronic inflammatory condition of the arterial wall that leads to the formation of vessel-occluding plaques within the subintimal space of middle-sized and larger arteries. While traditionally understood as a myeloid-driven lipid-storage disease, growing evidence suggests that the accumulation of low-density lipoprotein cholesterol (LDL-C) ignites an autoimmune response with CD4+ T-helper (TH) cells that recognize self-peptides from Apolipoprotein B (ApoB), the core protein of LDL-C. These autoreactive CD4+ T cells home to the atherosclerotic plaque, clonally expand, instruct other cells in the plaque, and induce clinical plaque instability. Recent developments in detecting antigen-specific cells at the single cell level have demonstrated that ApoB-reactive CD4+ T cells exist in humans and mice. Their phenotypes and functions deviate from classical immunological concepts of distinct and terminally differentiated TH immunity. Instead, ApoB-specific CD4+ T cells have a highly plastic phenotype, can acquire several, partially opposing and mixed transcriptional programs simultaneously, and transit from one TH subset into another over time. In this review, we highlight adaptive immune mechanisms in atherosclerosis with a focus on CD4+ T cells, introduce novel technologies to detect ApoB-specific CD4+ T cells at the single cell level, and discuss the potential impact of ApoB-driven autoimmunity in atherosclerosis.Keywords
Funding Information
- H2020 European Research Council (853425)
This publication has 265 references indexed in Scilit:
- Interleukin‐13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotypeEMBO Molecular Medicine, 2012
- How dendritic cells shape atherosclerosisTrends in Immunology, 2011
- Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune diseaseNature Medicine, 2011
- Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selectionJournal of Experimental Medicine, 2010
- Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosisJournal of Experimental Medicine, 2010
- Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosisJournal of Experimental Medicine, 2009
- IL-33 reduces the development of atherosclerosisJournal of Experimental Medicine, 2008
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- Direct access to CD4+ T cells specific for defined antigens according to CD154 expressionNature Medicine, 2005
- Inflammation in atherosclerosisNature, 2002